MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Depreciation & Amortization 2011-2026 | EW
Annual Depreciation & Amortization Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 155 M | 145 M | 140 M | 135 M | 107 M | 89.3 M | 77.4 M | 81.9 M | 71.2 M | 65.8 M | 68.6 M | 62.9 M | 53.7 M | 58 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157 M | 53.7 M | 97.8 M |
Quarterly Depreciation & Amortization Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 36.6 M | - | - | - | 38.5 M | - | - | - | 35.2 M | - | 104 M | - | 34.7 M | - | 102 M | - | 32.4 M | - | 74.6 M | 49 M | 24.5 M | - | 65.4 M | 42.3 M | 20.6 M | - | 57.5 M | 38.3 M | 19.1 M | - | 60.7 M | 40 M | 21.1 M | - | 52.1 M | 33.9 M | 15.9 M | - | 51.3 M | 32.8 M | 16 M | - | 50.3 M | 32.3 M | 16.2 M | - | 45.8 M | 28.8 M | 14.1 M | - | 42.2 M | 27.8 M | 13.8 M | - | 43.2 M | 29.3 M | 14.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | 13.8 M | 39.4 M |
Depreciation & Amortization of other stocks in the Medical devices industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
188 K | - | 37.08 % | $ 85.7 M |  USA |
 |
Axonics Modulation Technologies
AXNX
|
11.7 M | - | - | $ 3.31 B | USA |
 |
Sintx Technologies
SINT
|
319 K | $ 2.3 | -4.96 % | $ 6.38 M | USA |
 |
Dynatronics Corporation
DYNT
|
487 K | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
2.78 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
191 K | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
451 K | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
145 M | $ 166.05 | -6.36 % | $ 12.4 B | USA |
 |
Sensus Healthcare
SRTS
|
400 K | $ 3.79 | -5.61 % | $ 61.9 M | USA |
 |
Stryker Corporation
SYK
|
1.57 B | $ 328.87 | -1.15 % | $ 126 B | USA |
 |
Alphatec Holdings
ATEC
|
77.5 M | $ 10.97 | -4.78 % | $ 1.65 B | USA |
 |
Tactile Systems Technology
TCMD
|
6.64 M | $ 26.49 | -1.08 % | $ 606 M | USA |
 |
TELA Bio
TELA
|
630 K | $ 0.67 | -10.47 % | $ 31.5 M | USA |
 |
Conformis
CFMS
|
4.03 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
6.15 M | $ 0.38 | 1.99 % | $ 39.1 M | USA |
 |
Abbott Laboratories
ABT
|
1.43 B | $ 104.91 | 0.33 % | $ 183 B | USA |
 |
Tandem Diabetes Care
TNDM
|
17.7 M | $ 21.24 | -8.92 % | $ 1.44 B | USA |
 |
Cardiovascular Systems
CSII
|
3.69 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
424 K | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
1.21 M | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.37 B | $ 69.46 | -1.01 % | $ 103 B | USA |
 |
Avinger
AVGR
|
289 K | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
17.1 M | $ 35.4 | -3.38 % | $ 1.1 B | USA |
 |
Establishment Labs Holdings
ESTA
|
6.2 M | $ 56.7 | -5.36 % | $ 1.68 B |  Costa-rica |
 |
NanoVibronix
NAOV
|
1 K | - | - | $ 1.08 M | USA |
 |
Viemed Healthcare
VMD
|
28.6 M | $ 9.27 | 0.54 % | $ 361 M | USA |
 |
Cytosorbents Corporation
CTSO
|
1.57 M | $ 0.61 | 1.65 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
340 K | $ 2.14 | -5.73 % | $ 3.34 M | USA |
 |
Varex Imaging Corporation
VREX
|
23.2 M | $ 10.82 | 0.32 % | $ 448 M | USA |
 |
BIOLASE
BIOL
|
2.8 M | - | -13.19 % | $ 166 K | USA |
 |
Beyond Air
XAIR
|
3 M | $ 0.72 | 4.06 % | $ 48.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
4.22 M | $ 0.55 | -2.12 % | $ 73.5 M | USA |
 |
Inogen
INGN
|
20.7 M | $ 6.29 | -3.31 % | $ 167 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
996 M | $ 88.46 | -0.77 % | $ 18 B | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 11.16 | -2.19 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
21.1 M | $ 15.81 | -3.3 % | $ 371 M | USA |
 |
Invacare Corporation
IVC
|
15.5 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
421 K | - | 10.0 % | $ 610 K | USA |